AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
4.160
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
4.170
+0.010 (0.24%)
After-hours: Apr 28, 2026, 4:22 PM EDT
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $1.26 billion as of April 28, 2026. Its market cap has increased by 104.45% in one year.
Market Cap
1.26B
Enterprise Value
873.57M
1-Year Change
104.45%
Ranking
Category
Stock Price
$4.16
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $1.26B, a decrease of -91.95%. That is a compound annual growth rate of -37.40%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ArriVent BioPharma | 1.34B |
| Novavax | 1.34B |
| MapLight Therapeutics | 1.31B |
| Savara | 1.30B |
| GH Research | 1.26B |
| MoonLake Immunotherapeutics | 1.23B |
| Jade Biosciences | 1.23B |
| DBV Technologies | 1.18B |